James Silverman should tell the SI, LOUD AND CLEAR, why he considers Nortran a "scam stock". Such words are nasty, if not actionable, when used against a group of underpaid, overworked scientists, pharmaceutical professionals and experienced executives making history with SIGNIFICANT headway toward a new drug to prevent some of the 400,000 deaths annually that occur suddenly, soon after the onset of a myocardial infarction. Please, Mr. Silverman, READ nortran.com and call me personally at 1-800-330-9928 if you have any reason to doubt our integrity. I trust you will consider reversing your written opinion of Nortran, as posted on this thread (in the message as indicated above, number 153).
Sincerely yours,
Dr. Allen Bain |
